Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. (HOTH) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 22 transactions totaling $1.0M, demonstrating a bearish sentiment with -$975.4K in net insider flow. The most recent transaction on Aug 28, 2025 involved a transaction of 310,744 shares valued at $376.0K.
HOTH Insider Activity Summary
Who Is Buying HOTH Stock?
No significant insider buying has been recorded for HOTH in the recent period.
Who Is Selling HOTH Stock?
No significant insider selling has been recorded for HOTH in the recent period.
Is Hoth Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HOTH is bearish with an Insider Alignment Score of 2/100 and a net flow of -$975.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
HOTH Frequently Asked Questions
Understanding HOTH Insider Activity
Insider trading at Hoth Therapeutics, Inc. (HOTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading HOTH stock, having executed 22 transactions in the past 90 days. The most active insider is Anthony Hayes (Executive), who has made 5 transactions totaling $500.0K.
Related Tools
Track Hoth Therapeutics, Inc. Insider Activity
Get notified when executives and directors at HOTH file new Form 4 transactions